T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Humana
HUM
|
+$2.57B |
| 2 |
GE Aerospace
GE
|
+$1.8B |
| 3 |
UnitedHealth
UNH
|
+$1.63B |
| 4 |
Marriott International
MAR
|
+$1.62B |
| 5 |
Apple
AAPL
|
+$1.3B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$2.87B |
| 2 |
JPMorgan Chase
JPM
|
+$1.64B |
| 3 |
Nike
NKE
|
+$1.59B |
| 4 |
Becton Dickinson
BDX
|
+$1.46B |
| 5 |
Alibaba
BABA
|
+$1.32B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.97% |
| 2 | Healthcare | 18.52% |
| 3 | Consumer Discretionary | 13.26% |
| 4 | Financials | 12.08% |
| 5 | Communication Services | 10.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1901
Wolverine World Wide
WWW
$1.63B
| $591K | ﹤0.01% |
38,864
+5,381
| +16% | +$148K |
|
1902
NextCure
NXTC
$37.9M
| $588K | ﹤0.01% |
+1,321
| New | +$706K |
|
|
ALX
1903
Alexander's
ALX
$1.4B
| $587K | ﹤0.01% |
2,129
+314
| +17% | +$98.4K |
|
1904
Fortis
FTS
$28.8B
| $586K | ﹤0.01% |
15,365
+32
| +0.2% | +$1.31K |
|
1905
Shake Shack
SHAK
$2.98B
| $585K | ﹤0.01% |
15,502
+172
| +1% | +$10.2K |
|
|
MDC
1906
DELISTED
M.D.C. Holdings, Inc.
MDC
| $585K | ﹤0.01% |
27,217
-5,779
| -18% | -$202K |
|
1907
Park Hotels & Resorts
PK
$3.03B
| $584K | ﹤0.01% |
73,863
+9,249
| +14% | +$174K |
|
1908
ABM Industries
ABM
$2.82B
| $581K | ﹤0.01% |
23,861
+410
| +2% | +$14.1K |
|
1909
Unilever
UL
$135B
| $581K | ﹤0.01% |
10,209
+2,671
| +35% | +$168K |
|
|
DVAX
1910
DELISTED
Dynavax Technologies
DVAX
| $580K | ﹤0.01% |
164,353
+426
| +0.3% | +$1.98K |
|
1911
Nu Skin
NUS
$236M
| $580K | ﹤0.01% |
26,548
+7,330
| +38% | +$221K |
|
|
WBT
1912
DELISTED
Welbilt, Inc.
WBT
| $579K | ﹤0.01% |
112,894
-17,321
| -13% | -$208K |
|
|
GOOD
1913
Gladstone Commercial Corp
GOOD
$641M
| $576K | ﹤0.01% |
40,086
+152
| +0.4% | +$2.89K |
|
1914
Peapack-Gladstone Financial
PGC
$822M
| $576K | ﹤0.01% |
32,105
+139
| +0.4% | +$3.68K |
|
|
TIVO
1915
DELISTED
Tivo Inc
TIVO
| $576K | ﹤0.01% |
81,294
-6,480
| -7% | -$47.8K |
|
1916
Essential Properties Realty Trust
EPRT
$6.71B
| $574K | ﹤0.01% |
+43,979
| New | +$1.02M |
|
|
PRSU
1917
Pursuit Attractions and Hospitality Inc
PRSU
$1.29B
| $573K | ﹤0.01% |
26,974
+131
| +0.5% | +$6.75K |
|
|
INOV
1918
DELISTED
Inovalon Holdings, Inc. Class A Common Stock
INOV
| $573K | ﹤0.01% |
34,409
+423
| +1% | +$8.03K |
|
1919
nLIGHT
LASR
$2.9B
| $571K | ﹤0.01% |
54,473
-68,528
| -56% | -$1.17M |
|
1920
Appian
APPN
$2.65B
| $570K | ﹤0.01% |
14,164
-1,676
| -11% | -$77.9K |
|
1921
Cerus
CERS
$572M
| $570K | ﹤0.01% |
122,610
+21,137
| +21% | +$95.7K |
|
1922
Goodyear
GT
$1.78B
| $570K | ﹤0.01% |
97,976
+317
| +0.3% | +$3.46K |
|
1923
Apogee Enterprises
APOG
$888M
| $569K | ﹤0.01% |
27,328
-173
| -0.6% | -$5.06K |
|
|
DSPG
1924
DELISTED
DSP Group Inc
DSPG
| $569K | ﹤0.01% |
42,490
+11,010
| +35% | +$158K |
|
1925
CNX Resources
CNX
$5.23B
| $568K | ﹤0.01% |
106,799
+1,100
| +1% | +$7.31K |
|
Similar funds
T. Rowe Price Associates's Q1 2020 Portfolio in Review
As of Q1 2020, T. Rowe Price Associates held 2,612 positions worth $632B, down 18% from $771B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
T. Rowe Price Associates's Q1 2020 filing shows 87 new, 1,525 increased, 823 reduced and 103 closed positions. Its largest new stake was Philips: 33,363,001 shares worth $1.07B. The largest sale was Boeing, an estimated $2.87B.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q1 2020 buy was Philips: 33,363,001 shares worth $1.07B.
- T. Rowe Price Associates added most to Humana in Q1 2020, an estimated $2.57B increase.
- T. Rowe Price Associates's biggest Q1 2020 reduction was Boeing, cutting an estimated $2.87B.
- T. Rowe Price Associates fully exited Wellcare Health Plans, Inc. in Q1 2020, selling an estimated $846M.
- T. Rowe Price Associates's ten largest holdings make up 24% of its $632B portfolio in Q1 2020.
- T. Rowe Price Associates opened 87 new positions and closed 103 in Q1 2020.
- T. Rowe Price Associates's portfolio value fell 18% quarter-over-quarter to $632B.
Based on T. Rowe Price Associates's 13F filing for Q1 2020, filed 15 May 2020.